» Articles » PMID: 39961901

Exploring the Therapeutic Potential of MOTS-c in Age-related Macular Degeneration: from Cellular Responses to Patient-derived Cybrids

Overview
Journal Hum Cell
Publisher Springer
Specialty Cell Biology
Date 2025 Feb 17
PMID 39961901
Authors
Affiliations
Soon will be listed here.
Abstract

Age-related macular degeneration (AMD), the leading cause of irreversible vision loss in the US, is on the rise among the elderly. Uncontrolled mitochondria-derived peptide production from mtDNA disruption and 16S or 12S rRNA damage could worsen AMD. Our previous work has shown that Humanin G possesses cytoprotective effects in retinal pigment epithelial (RPE) cells. However, MOTS-c, a highly efficient mitochondrial peptide, has yet to be evaluated on retinal cell survival. In this study, we show that there are differences in effects between wild-type (wt-) and differentiated ARPE19 cells (diff-ARPE19), implying that the cellular differentiation status may influence how cells respond to MOTS-c. MOTS-c has dose-dependent effects on apoptosis, inflammation, and mitochondrial biogenesis in diff-ARPE19 cells. Lower doses (500 nM) have more significant impacts than 5 µM concentrations. In diff-ARPE19 cells, a lower dose of MOTS-c can reduce the negative impact of hypoxia on cellular survival and gene expression, including apoptosis (CASP3, CASP9), mitochondrial biogenesis (TFAM, PGC-1α), and metabolic sensor (AMPK). However, it had no significant effect on ROS levels or NRF1 expression, regardless of MOTS-c dose. Exposing diff-ARPE19 cells to varied MOTS-c dosages before and after therapy in a chemically induced hypoxic environment yields no extra benefits as compared to MOTS-c treatment alone. MOTS-c had different effects on the expression of genes linked with apoptosis, mitochondrial biogenesis, and antioxidant activity in AMD patients versus age-matched control cybrids. The MOTS-c peptide appears to enhance cellular metabolism and regulate gene expression, which could potentially provide therapeutic benefits in AMD.

References
1.
Nashine S, Cohen P, Wan J, Kenney M . Effect of Humanin G (HNG) on inflammation in age-related macular degeneration (AMD). Aging (Albany NY). 2022; 14(10):4247-4269. PMC: 9186758. DOI: 10.18632/aging.204074. View

2.
Samuel W, Jaworski C, Postnikova O, Kutty R, Duncan T, Tan L . Appropriately differentiated ARPE-19 cells regain phenotype and gene expression profiles similar to those of native RPE cells. Mol Vis. 2017; 23:60-89. PMC: 5360456. View

3.
Cheng Z, Yao W, Zheng J, Ding W, Wang Y, Zhang T . A derivative of betulinic acid protects human Retinal Pigment Epithelial (RPE) cells from cobalt chloride-induced acute hypoxic stress. Exp Eye Res. 2018; 180:92-101. DOI: 10.1016/j.exer.2018.12.011. View

4.
Hurley J, Lindsay K, Du J . Glucose, lactate, and shuttling of metabolites in vertebrate retinas. J Neurosci Res. 2015; 93(7):1079-92. PMC: 4720126. DOI: 10.1002/jnr.23583. View

5.
Ames 3rd A, Li Y, Heher E, Kimble C . Energy metabolism of rabbit retina as related to function: high cost of Na+ transport. J Neurosci. 1992; 12(3):840-53. PMC: 6576058. View